Patent Term Extension Application for CONTEPO (fosfomycin disodium), Patent No. 11,541,064 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1002

Patent Term Extension Application for CONTEPO (fosfomycin disodium), Patent No. 11,541,064

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter to U.S. Patent and Trademark Office	Apr 20, 2026	--

CDER

Patent Term Extension Application

McDonnell Boehnen Hulbert & Berghoff LLP

Meitheal Pharmaceuticals, Inc.

CONTEPO (fosfomycin disodium)

Patent No. 11,541,064

OPEN